Opiate Receptor Drugs – To Cycle or Not to Cycle Dosing? - Paul Anderson, NMD (2021 Conference) (LDN, low dose naltrexone)

Mold toxicity - Leonard Weinstock, MD (2021 Conference) (LDN, low dose naltrexone)

Drug Resistant Depression - Elizabeth Livengood, NMD (2021 Conference) (LDN, low dose naltrexone)

Dr. Elizabeth Livengood’s presentation is on identifying different causes of depression, identifying depression, hyperthyroidism connections, identifying patient profiles who fit these descriptions, and understanding how to treat them. 

Pain - Samyadev Datta, MD (2021 Conference) (LDN, low dose naltrexone)

LDN Research Trust 2021 Conference - Friday Morning

Early Biomarkers of a Brain on Fire - Tom O’Bryan, DC, CCN, DACBN (2021 Conference) (LDN, low dose naltrexone)

LDN Research Trust 2021 Conference - Friday Morning

History, Pharmacology and Mechanism - Stephen Dickson, BSC (hons) MRPharmS (2021 Conference) (LDN, low dose naltrexone)

LDN Research Trust 2021 Conference - Friday Morning

Jill Cottel, MD - Vitamin D and Autoimmune Disease: A Systematic Review of the Literature (2017 Conference) (LDN, low dose naltrexone)

Beth Livengood, ND - Rheumatoid Arthritis Case Study (2017 Conference) (LDN, low dose naltrexone)

Etiology of rheumatoid arthritis (RA) is autoimmune; has an inflammatory component including food sensitivities. Low Vitamin D a component, as in many diseases. LDN in two cases of RA.

Ginevra Liptan, MD - Alternative Strategies for Fibromyalgia Pain (2017 Conference) (LDN, low dose naltrexone)

Beth Livengood, ND - Gastroparesis Case Study (2017 Conference) (LDN, low dose naltrexone)

A case of gastroparesis and how low dose naltrexone helped this patient. Causes, symptoms, diagnostic findings, similar pathologies, demographics, and treatments, including diet, low dose naltrexone, acupuncture, etc; and the mechanisms of action of these treatments.